Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALEMBIC PHARMS LTD

  • FDA Approval
  • Jan. 20, 2023, 01:41 UTC
  • 29
  • 0 comments

FDA approve ACALABRUTINIB

Comment Full text

TORRENT

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 29
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

ALLERQUEST

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 29
  • 0 comments

FDA approve BENZYLPENICILLOYL POLYLYSINE

Comment Full text

MICRO LABS

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 28
  • 0 comments

FDA approve AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Comment Full text

ALEMBIC PHARMS

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 29
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 121
  • 0 comments

FDA approve GALANTAMINE HYDROBROMIDE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 27
  • 0 comments

FDA approve CAPREOMYCIN SULFATE

Comment Full text

SUN PHARM INDS INC

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 25
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 29
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

PAR PHARM

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 25
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text
  • Previous
  • 896
  • 897
  • 898
  • 899
  • 900
  • Next

Search

News categories

  • Technical Exchange News(12253)
  • Event(6229)
  • SEC News(265345)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154896)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin